Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNYSE:AET
Previous Symbol
CUSIP00817Y10
Phone860-273-0123
Debt
Debt-to-Equity Ratio0.42
Current Ratio0.79
Quick Ratio0.79
Price-To-Earnings
Trailing P/E Ratio21.57
Forward P/E Ratio18.69
P/E Growth1.82
Sales & Book Value
Annual Sales$60.54 billion
Price / Sales1.15
Cash Flow$12.4386 per share
Price / Cash Flow17.10
Book Value$56.70 per share
Price / Book3.75
Profitability
EPS (Most Recent Fiscal Year)$9.86
Net Income$1.90 billion
Net Margins5.99%
Return on Equity20.78%
Return on Assets6.22%
Miscellaneous
Employees47,950
Outstanding Shares327,400,000
Market Cap$69.64 billion
OptionableOptionable
Aetna (NYSE:AET) Frequently Asked Questions
What is Aetna's stock symbol?
Aetna trades on the New York Stock Exchange (NYSE) under the ticker symbol "AET."
How often does Aetna pay dividends? What is the dividend yield for Aetna?
Aetna declared a quarterly dividend on Friday, September 28th. Shareholders of record on Wednesday, October 24th will be given a dividend of $0.50 per share on Thursday, November 1st. This represents a $2.00 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date of this dividend is Tuesday, October 23rd. View Aetna's Dividend History.
How will Aetna's stock buyback program work?
Aetna announced that its Board of Directors has authorized a stock repurchase plan on Friday, April 7th 2017, which allows the company to repurchase $4,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy up to 98% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board of directors believes its stock is undervalued.
How were Aetna's earnings last quarter?
Aetna Inc (NYSE:AET) announced its quarterly earnings data on Tuesday, October, 30th. The company reported $2.96 EPS for the quarter, beating the Zacks' consensus estimate of $2.83 by $0.13. The business had revenue of $15.48 billion for the quarter, compared to analysts' expectations of $15.40 billion. Aetna had a return on equity of 20.78% and a net margin of 5.99%. The company's quarterly revenue was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.45 earnings per share. View Aetna's Earnings History.
When is Aetna's next earnings date?
What price target have analysts set for AET?
8 equities research analysts have issued 12 month price objectives for Aetna's stock. Their forecasts range from $179.00 to $212.00. On average, they anticipate Aetna's share price to reach $203.6250 in the next twelve months. This suggests that the stock has a possible downside of 4.3%. View Analyst Price Targets for Aetna.
What is the consensus analysts' recommendation for Aetna?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aetna in the last year. There are currently 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Aetna.
What are Wall Street analysts saying about Aetna stock?
Here are some recent quotes from research analysts about Aetna stock:
- 1. According to Zacks Investment Research, "Shares of Aetna have outperformed the industry's growth in six months. Moreover, it has witnessed its 2018 earnings move upward over the past seven days. The recent sale of its U.S. Group Life and Disability business will enable the company to focus on its core growth areas. It is on track to be acquired by CVS Health and has announced that it will sell Medicare Part D business. The DoJ's approval takes the deal toward closure, which is scheduled in the fourth quarter of 2018. Its revenues suffered a decline in 2017, improved in the first nine months of 2018 but should remain subdued in the coming quarters. Declining membership and rising expenses are some other concerns." (11/28/2018)
- 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on AET shares and increase our price target to $204 from $202 previously. Our price target is based on the implied CVS Health (CVS – Not Covered) acquisition value. BMO on Tuesday, October 30, AET reported 3Q18 results. Adjusted EPS were exactly in line with our estimate but nicely above FactSet consensus. Revenue was slightly below our estimate but above consensus. MLR was above our estimate and consensus. Operating expenses offset the increase in MLR, relative to ur estimate. As reminder, the company has not provided 2018 guidance given the pending CVS merger." (10/30/2018)
Has Aetna been receiving favorable news coverage?
Headlines about AET stock have been trending very positive this week, InfoTrie reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aetna earned a news impact score of 3.9 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near term.
Who are some of Aetna's key competitors?
Who are Aetna's key executives?
Aetna's management team includes the folowing people:
- Mr. Mark Thomas Bertolini, Chairman & CEO (Age 61)
- Ms. Karen Sue Lynch, Pres (Age 55)
- Mr. Shawn Michael Guertin, Exec. VP, CFO & Chief Enterprise Risk Officer (Age 54)
- Mr. Richard Michael Jelinek, Exec. VP and Head of Enterprise Strategy & Integration (Age 52)
- Ms. Margaret M. McCarthy, Exec. VP of Operations & Technology (Age 64)
Who are Aetna's major shareholders?
Aetna's stock is owned by many different of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (7.14%), BlackRock Inc. (7.13%), Capital International Investors (3.84%), FMR LLC (2.77%), Capital World Investors (2.30%) and Dimensional Fund Advisors LP (1.11%). Company insiders that own Aetna stock include Francis S Soistman Jr, Karen S Lynch, Margaret M Mccarthy, Mark T Bertolini and Shawn M Guertin. View Institutional Ownership Trends for Aetna.
Which institutional investors are selling Aetna stock?
AET stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, PointState Capital LP, Abrams Capital Management L.P., OZ Management LP, Deutsche Bank AG, Mitsubishi UFJ Trust & Banking Corp, Great Lakes Advisors LLC and Wells Fargo & Company MN. View Insider Buying and Selling for Aetna.
Which institutional investors are buying Aetna stock?
AET stock was purchased by a variety of institutional investors in the last quarter, including Capital International Investors, FMR LLC, Manikay Partners LLC, Rehmann Capital Advisory Group, Morgan Stanley, Canyon Capital Advisors LLC, Sandell Asset Management Corp. and Diamond Hill Capital Management Inc.. View Insider Buying and Selling for Aetna.
How do I buy shares of Aetna?
Shares of AET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Aetna's stock price today?
One share of AET stock can currently be purchased for approximately $212.70.
How big of a company is Aetna?
Aetna has a market capitalization of $69.64 billion and generates $60.54 billion in revenue each year. The company earns $1.90 billion in net income (profit) each year or $9.86 on an earnings per share basis. Aetna employs 47,950 workers across the globe.
What is Aetna's official website?
How can I contact Aetna?
Aetna's mailing address is 151 FARMINGTON AVENUE, HARTFORD CT, 06156. The company can be reached via phone at 860-273-0123 or via email at [email protected]
MarketBeat Community Rating for Aetna (NYSE AET)
MarketBeat's community ratings are surveys of what our community members think about Aetna and other stocks. Vote "Outperform" if you believe AET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AET will underperform the S&P 500 over the long term. You may vote once every thirty days.
